- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Jason Mitchell Details the Importance of Data in Value-Based Care
Data is critical to all value-based care, said Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.
Data is critical to all value-based care, said Jason Mitchell, MD, chief medical and clinical transformation officer, Presbyterian Healthcare Services.
Transcript
How important is the availability of data analytics to be able to compare how a provider or health system compares with others and to learn best practices?
Data is critical to all value-based care. If you can’t know what your outcomes are, then you can’t test, and if you can’t test, you can’t improve. So, you have to have core data to do that work. I think it’s important to remember that all data is wrong. As you engage with clinicians, really showing them here’s what we see in the data, what does it mean to you, and you glean a lot more information from it and iterate on it. I think without the data, how do you know that you’re improving? How do you know what your baseline is? And, how do you know where you have variation? So, we’ve got to have the data.
I think what’s new in thinking is that the data’s no longer your clinical data. You have to think about your pharmacy data, your fill data for pharmacy. You have to think about social determinants, and there’s so much data on those aspects that you can combine those together in a way to give you new insights.
NGS-Based Test Accurately Detects Post–Allo-HSCT Relapse in AML, MDS
February 21st 2025The next-generation sequencing (NGS)–based AlloHeme test accurately predicted relapse following allogeneic hematopoietic stem cell transplantation (allo-HSCT) in acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).
Read More
Frameworks for Advancing Health Equity: Youth Behavioral Health Strategy Program
September 17th 2024Chris Barton, LCSW, of Horizon Blue Cross Blue Shield of New Jersey, explores how the Youth Behavioral Health Strategy program focuses on addressing the specific needs of youth with mental health and substance use issues through a comprehensive approach.
Listen
“Expanding Access Isn’t Just About Fairness—It’s About Building Better Treatments for Everyone”
February 16th 2025Regina Barragan-Carrillo, MD, a postdoctoral fellow at City of Hope Comprehensive Cancer Center, discussed findings that show 76% of renal cell carcinoma trials take place in wealthy countries, amid news that clinical trial access for the world's poor may become even more challenging.
Read More
Amid Debate Over Diversity, RCC Trials Still Struggle to Reflect Patient Populations
February 16th 2025Abstracts presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium reflect the ongoing challenge with enrolling diverse patient populations in trials, despite stated goals.
Read More
